Free Trial

Alterity Therapeutics (ATHE) SEC Filings & 10K Form

Alterity Therapeutics logo
$2.20 +0.10 (+4.76%)
(As of 12/20/2024 05:51 PM ET)

Recent Alterity Therapeutics SEC Filings

DateFilerForm TypeView
12/04/2024
6:35 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/22/2024
5:58 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/22/2024
6:10 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/22/2024
6:14 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/19/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/12/2024
5:27 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2024
7:00 PM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2024
7:48 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/10/2024
8:15 PM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2024
5:26 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/02/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
5:20 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2024
3:30 PM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2024
3:32 PM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2024
3:33 PM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2024
3:40 PM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
09/23/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
5:03 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/29/2024
5:07 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
6:06 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2024
5:23 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/24/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/19/2024
5:31 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/19/2024
5:22 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/18/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/17/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2024
5:51 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2024
5:19 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/13/2024
7:28 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2024
7:35 PM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
5:15 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
5:13 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2024
8:18 PM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis (Ad)

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.
03/04/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/04/2024
7:01 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/22/2024
7:53 PM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/22/2024
7:55 PM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/15/2024
4:28 PM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 424B5
02/15/2024
4:29 PM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/06/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/02/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/01/2024
7:39 PM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2024
5:12 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/18/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/11/2024
4:19 PM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/11/2024
4:16 PM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/10/2024
5:03 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2024
7:01 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2024
7:02 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2024
7:03 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/05/2024
5:24 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/05/2024
5:27 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/02/2024
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/02/2024
7:02 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/02/2024
7:04 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/29/2023
7:00 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/29/2023
7:02 AM
ALTERITY THERAPEUTICS LTD (Filer)
Alterity Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ATHE) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners